JERUSALEM, Aug. 25 (Xinhua) -- Israel and South Korea have launched a plan for funding joint projects of companies from both countries in the field of bio-convergence, the Israel Innovation Authority (IIA) said Tuesday.
Bio-convergence integrates biology with additional disciplines from engineering such as electronics, artificial intelligence (AI), physics, computer science, nanotechnology, material science, and advanced genetic engineering.
According to the IIA, bio-convergence is one of the most significant emerging growth engines for Israeli hi-tech.
The funding, at a total of about 4 million U.S. dollars, will be done through the bi-national foundation Korea-Israel Industrial R&D Foundation (KORIL-RDF), owned and financed jointly by both governments.
As part of the plan, groundbreaking ventures in several bio-convergence areas will be funded, including nano robotics for bio-advanced engineered drug delivery and diagnostics systems, therapeutics discovery systems, tissue engineering, and bioelectronics. Enditem
